scispace - formally typeset
A

Andrea Repele

Researcher at Great Ormond Street Hospital

Publications -  7
Citations -  108

Andrea Repele is an academic researcher from Great Ormond Street Hospital. The author has contributed to research in topics: Myocyte & Stem cell. The author has an hindex of 4, co-authored 4 publications receiving 100 citations. Previous affiliations of Andrea Repele include University of Padua & Royal Veterinary College.

Papers
More filters
Journal ArticleDOI

Amniotic fluid stem cells restore the muscle cell niche in a HSA-Cre, Smn(F7/F7) mouse model.

TL;DR: It is demonstrated that tail vein transplantation of mouse amniotic fluid stem (AFS) cells enhances the muscle strength and improves the survival rate of the affected animals and secondary transplants of satellite cells derived from treated mice show that AFS cells integrate into the muscle stem cell compartment and have long‐term muscle regeneration capacity indistinguishable from that of wild‐type‐derived SC.
Journal ArticleDOI

Human amniotic fluid stem cell differentiation along smooth muscle lineage

TL;DR: It is shown here that hAFSCs under selective culture conditions are able to give rise to functional SMCs, for the first time that efficient SMCs can be obtained from human amniotic fluid stem cells.
Journal ArticleDOI

Culturing muscle fibres in hanging drop: A novel approach to solve an old problem

TL;DR: The hanging drop system is used to culture SCs in a three‐dimensional environment and thus, to monitor them in their original niche and to solve the mixture of their subpopulations that exist within muscle.
Journal ArticleDOI

Cell metabolism sets the differences between subpopulations of satellite cells (SCs).

TL;DR: These experimental observations report novel physiological features in the cell biology of SCs and refer to an intrinsic heterogeneity within which their stemness may reside.
Journal ArticleDOI

A Chemically Inducible IL-2 Receptor Signaling Complex Allows for Effective In Vitro and In Vivo selection of Engineered CD4+ T cells.

TL;DR: In this article , a cell-intrinsic selection system that leverages the dependency of primary T cells on IL-2 signaling was proposed to enrich and expand therapeutic cells at clinical scale.